ONE OF THE WORLD'S
LARGEST HUMAN DNA
The Regeneron Genetics Center (RGC) has built one of the world’s most comprehensive genetics databases, pairing the sequenced exomes and de-identified electronic health records of more than 400,000 people so far. Building upon our strengths in mouse genetics and genetics-driven drug discovery, this information will allow us to elucidate, on a large scale, genetic factors that cause or influence a range of human diseases. We believe that this knowledge can advance basic science around the world, provide clinically valuable insights to physicians and patients and ultimately make drug development faster and more precise.
Our team conducts gene sequencing projects, functional biology, disease modeling and the translation of genetics findings into Regeneron’s preclinical and clinical pipelines. We are using our unique database and state-of-the-art analysis capabilities to identify new drug targets and therapeutic indications, to validate our existing programs and to build better-informed clinical trials. Our explorations include Mendelian and family frameworks, large-scale population genetics (both common and rare variants) and gene-gene interactions.
exomes sequenced to date
SCIENTIFIC ADVISORY BOARD
Accelerating drug discovery
and development with genetics research
THE JOURNEY OF AN IDEA